These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6662280)

  • 1. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Gilchrist BJ; Wyse BM
    Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Wyse BM; Gilchrist BJ
    Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects.
    Shargill NS; Tatoyan A; Fukushima M; Antwi D; Bray GA; Chan TM
    Metabolism; 1986 Jan; 35(1):64-70. PubMed ID: 3510364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciglitazone, a new hypoglycaemic agent. 4. Effect on pancreatic islets of C57BL/6J-ob/ob and C57BL/KsJ-db/db mice.
    Diani AR; Peterson T; Sawada GA; Wyse BM; Gilchrist BJ; Hearron AE; Chang AY
    Diabetologia; 1984 Aug; 27(2):225-34. PubMed ID: 6386585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciglitazone, a hypoglycemic agent: early effects on the pancreatic islets of ob/ob mice.
    Colca JR; Wyse BM; Sawada G; Jodelis KS; Connell CL; Fletcher-McGruder BL; Palazuk BJ; Diani AR
    Metabolism; 1988 Mar; 37(3):276-80. PubMed ID: 3278192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
    Stevenson RW; Hutson NJ; Krupp MN; Volkmann RA; Holland GF; Eggler JF; Clark DA; McPherson RK; Hall KL; Danbury BH
    Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism and recycling by hepatocytes of OB/OB and ob/ob mice.
    Lahtela JT; Wals PA; Katz J
    Am J Physiol; 1990 Sep; 259(3 Pt 1):E389-96. PubMed ID: 2169201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice.
    Bandsma RH; Grefhorst A; van Dijk TH; van der Sluijs FH; Hammer A; Reijngoud DJ; Kuipers F
    Diabetologia; 2004 Nov; 47(11):2022-31. PubMed ID: 15599701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
    Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
    Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluconeogenesis in perfused livers of genetically obese-hyperglycemic (ob/ob) mice.
    Lombardo YB; Menahan LA
    Horm Metab Res; 1979 Jan; 11(1):9-14. PubMed ID: 428917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adrenalectomy on the metabolism of glucose in obese (C57 Bl/6J ob/ob) mice.
    Wittmers LE; Haller EW
    Metabolism; 1983 Dec; 32(12):1093-100. PubMed ID: 6645960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.
    Fujiwara T; Okuno A; Yoshioka S; Horikoshi H
    Metabolism; 1995 Apr; 44(4):486-90. PubMed ID: 7723671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism in the obese hyperglycaemic (C57B1/6 ob/ob) mouse: the effects of fasting on glucose turnover rates.
    Smith SA; Cawthorne MA; Simson DL
    Diabetes Res; 1986 Feb; 3(2):83-6. PubMed ID: 3698484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice.
    Kreutner W; Springer SC; Sherwood JE
    Am J Physiol; 1975 Feb; 228(2):663-71. PubMed ID: 804818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic agent YM440 ameliorates the impaired hepatic glycogenesis after glucose loading by increasing glycogen synthase activity in obese Zucker rats.
    Kurosaki E; Momose K; Nakano R; Shimaya A; Suzuki T; Shibasaki M; Shikama H
    Jpn J Pharmacol; 2002 Jul; 89(3):274-81. PubMed ID: 12184733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and functional characterization of 1,4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice.
    Fosgerau K; Westergaard N; Quistorff B; Grunnet N; Kristiansen M; Lundgren K
    Arch Biochem Biophys; 2000 Aug; 380(2):274-84. PubMed ID: 10933882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
    Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
    Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats.
    Kurosaki E; Nakano R; Momose K; Shimaya A; Suzuki T; Shibasaki M; Shikama H
    Eur J Pharmacol; 2003 May; 468(2):151-8. PubMed ID: 12742522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.